Taysha Gene Therapies, Inc. (TSHA) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to loss of$0.10 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.08 per share when it actually produced a loss of$0.07, delivering a surprise of 12.50%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.Taysha Gene Therapies, which b ...